Drug profile · INN
trifluoperazine hydrochloride
TRIFLUOPERAZINE HYDROCHLORIDE
trifluoperazine hydrochloride (TRIFLUOPERAZINE HYDROCHLORIDE) is a d2-like dopamine receptor antagonist. Route of administration: injection. Current US regulatory status: approved.
Drug details — trifluoperazine hydrochloride
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
trifluoperazine hydrochloride (TRIFLUOPERAZINE HYDROCHLORIDE) is a d2-like dopamine receptor antagonist. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
D2-like dopamine receptor antagonist
Primary target: D2-like dopamine receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is trifluoperazine hydrochloride?
trifluoperazine hydrochloride (TRIFLUOPERAZINE HYDROCHLORIDE) is a d2-like dopamine receptor antagonist. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for trifluoperazine hydrochloride?
TRIFLUOPERAZINE HYDROCHLORIDE is a marketed brand name for trifluoperazine hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of trifluoperazine hydrochloride?
trifluoperazine hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.